U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
HLL1
Preferred Name English
MILATUZUMAB
INN   MART.   USAN   WHO-DD  
USAN   INN  
Official Name English
MILATUZUMAB [USAN]
Common Name English
Milatuzumab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CLASS II ANTIGEN INVARIANT CHAIN) (HUMAN-MOUSE MONOCLONAL HLL1 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HLL1 .KAPPA.-CHAIN, DIMER
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CLASS II ANTIGEN INVARIANT CHAIN) (HUMAN- MOUSE MONOCLONAL HLL1 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HLL1 .KAPPA.-CHAIN, DIMER
Common Name English
MILATUZUMAB [MART.]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CLASS II ANTIGEN INVARIANT CHAIN) (HUMAN- MOUSE MONOCLONAL HLL1 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HLL1 .KAPPA.-CHAIN, DIMER
Common Name English
IMMU-115
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CLASS II ANTIGEN INVARIANT CHAIN) (HUMAN-MOUSE MONOCLONAL HLL1 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HLL1 .KAPPA.-CHAIN, DIMER
Common Name English
milatuzumab [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 20:32:49 GMT 2025 , Edited by admin on Mon Mar 31 20:32:49 GMT 2025
FDA ORPHAN DRUG 255807
Created by admin on Mon Mar 31 20:32:49 GMT 2025 , Edited by admin on Mon Mar 31 20:32:49 GMT 2025
NCI_THESAURUS C129822
Created by admin on Mon Mar 31 20:32:49 GMT 2025 , Edited by admin on Mon Mar 31 20:32:49 GMT 2025
FDA ORPHAN DRUG 256608
Created by admin on Mon Mar 31 20:32:49 GMT 2025 , Edited by admin on Mon Mar 31 20:32:49 GMT 2025
EU-Orphan Drug EU/3/08/601
Created by admin on Mon Mar 31 20:32:49 GMT 2025 , Edited by admin on Mon Mar 31 20:32:49 GMT 2025
Code System Code Type Description
ChEMBL
CHEMBL1743040
Created by admin on Mon Mar 31 20:32:49 GMT 2025 , Edited by admin on Mon Mar 31 20:32:49 GMT 2025
PRIMARY
DRUG BANK
DB12943
Created by admin on Mon Mar 31 20:32:49 GMT 2025 , Edited by admin on Mon Mar 31 20:32:49 GMT 2025
PRIMARY
USAN
TT-25
Created by admin on Mon Mar 31 20:32:49 GMT 2025 , Edited by admin on Mon Mar 31 20:32:49 GMT 2025
PRIMARY
SMS_ID
100000169023
Created by admin on Mon Mar 31 20:32:49 GMT 2025 , Edited by admin on Mon Mar 31 20:32:49 GMT 2025
PRIMARY
EVMPD
SUB182652
Created by admin on Mon Mar 31 20:32:49 GMT 2025 , Edited by admin on Mon Mar 31 20:32:49 GMT 2025
PRIMARY
CAS
899796-83-9
Created by admin on Mon Mar 31 20:32:49 GMT 2025 , Edited by admin on Mon Mar 31 20:32:49 GMT 2025
PRIMARY
FDA UNII
2OP4E0GC6V
Created by admin on Mon Mar 31 20:32:49 GMT 2025 , Edited by admin on Mon Mar 31 20:32:49 GMT 2025
PRIMARY
INN
8922
Created by admin on Mon Mar 31 20:32:49 GMT 2025 , Edited by admin on Mon Mar 31 20:32:49 GMT 2025
PRIMARY
NCI_THESAURUS
C66983
Created by admin on Mon Mar 31 20:32:49 GMT 2025 , Edited by admin on Mon Mar 31 20:32:49 GMT 2025
PRIMARY
WIKIPEDIA
MILATUZUMAB
Created by admin on Mon Mar 31 20:32:49 GMT 2025 , Edited by admin on Mon Mar 31 20:32:49 GMT 2025
PRIMARY
ACTIVE MOIETY
MILATUZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966